Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
MCRB — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

8.76

Margin Of Safety %

Put/Call OI Ratio

0.49

EPS Next Q Diff

-0.29

EPS Last/This Y

-9.83

EPS This/Next Y

-1.09

Price

7.89

Target Price

22

Analyst Recom

1

Performance Q

-2.94

Upside

-924.0%

Beta

0.14

Ticker: MCRB



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23MCRB8.020.540.004061
2026-04-24MCRB8.210.54999.994061
2026-04-27MCRB7.280.540.734062
2026-04-28MCRB7.030.550.114121
2026-04-29MCRB6.990.540.134178
2026-04-30MCRB7.450.540.134178
2026-05-01MCRB7.690.530.244219
2026-05-04MCRB7.70.540.164217
2026-05-05MCRB7.380.541.334232
2026-05-06MCRB8.080.541.334238
2026-05-07MCRB7.610.540.584243
2026-05-08MCRB7.630.540.054256
2026-05-11MCRB7.930.530.124302
2026-05-12MCRB7.910.530.124302
2026-05-13MCRB7.780.520.014413
2026-05-14MCRB7.970.49999.994561
2026-05-15MCRB7.620.490.004562
2026-05-18MCRB7.630.490.004517
2026-05-19MCRB7.470.490.114547
2026-05-20MCRB7.520.493.504565
2026-05-21MCRB8.020.490.004573
2026-05-22MCRB7.9650.49999.994573
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23MCRB8.1016.0- -8.23
2026-04-24MCRB8.1016.0- -8.23
2026-04-27MCRB7.3016.0- -8.23
2026-04-28MCRB7.0516.0- -8.23
2026-04-30MCRB7.4316.0- -8.23
2026-05-01MCRB7.6216.0- -8.23
2026-05-04MCRB7.7416.0- -8.23
2026-05-05MCRB7.4316.0- -8.23
2026-05-06MCRB8.0516.0- -8.23
2026-05-07MCRB7.6816.0- -8.23
2026-05-08MCRB7.5216.0- -9.19
2026-05-11MCRB7.97- - -9.19
2026-05-12MCRB7.80- - -9.19
2026-05-13MCRB7.80- - -9.19
2026-05-14MCRB7.91- - -9.19
2026-05-15MCRB7.73- - -9.19
2026-05-18MCRB7.59-1.3- -9.19
2026-05-19MCRB7.46-1.3- -9.19
2026-05-20MCRB7.52-1.3- -9.19
2026-05-21MCRB8.02-1.3- -9.19
2026-05-22MCRB7.89-1.3- -9.19
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1



22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23MCRB-0.133.548.25
2026-04-24MCRB-0.133.548.25
2026-04-27MCRB-0.133.548.08
2026-04-28MCRB-0.133.548.08
2026-04-29MCRB-0.133.548.08
2026-04-30MCRB-0.133.548.08
2026-05-01MCRB-0.133.548.04
2026-05-04MCRB-0.133.358.04
2026-05-05MCRB-0.133.358.04
2026-05-06MCRB-0.133.358.04
2026-05-07MCRB-0.133.358.04
2026-05-08MCRB-0.133.358.04
2026-05-11MCRB-0.133.336.93
2026-05-12MCRB-0.263.337.43
2026-05-13MCRB-0.133.337.43
2026-05-14MCRB-0.133.337.39
2026-05-15MCRB-0.133.337.39
2026-05-18MCRB-0.133.667.38
2026-05-19MCRB-0.023.667.38
2026-05-20MCRB-0.043.667.38
2026-05-21MCRB-0.043.668.76
2026-05-22MCRB-0.033.668.76
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS​

-2.08

Avg. EPS Est. Current Quarter

-2.3

Avg. EPS Est. Next Quarter

-2.37

Insider Transactions

-0.03

Institutional Transactions

3.66

Beta

0.14

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

6

Growth Score

22

Sentiment Score

36

Actual DrawDown %

98.4

Max Drawdown 5-Year %

-98.6

Target Price

22

P/E

Forward P/E

PEG

P/S

66.7

P/B

2.87

P/Free Cash Flow

EPS

-5.02

Average EPS Est. Cur. Y​

-9.19

EPS Next Y. (Est.)

-10.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-4088.84

Relative Volume

0.44

Return on Equity vs Sector %

-204

Return on Equity vs Industry %

-188.4

EPS 1 7Days Diff

-1

EPS 1 30Days Diff

-0.96

EBIT Estimation

◆ MCRB Healthcare
$7.92
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
13/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
5/10
RSI
49.2
Range 1M
62.1%
Sup Dist
3%
🚀
Momentum Growth
Ride accelerating trends
N/A
16 /100
WEAK
Momentum
1/25
Growth
4/30
Estimates
1/20
Inst/Vol
5/15
Options
5/10
EPS Yr
-1535.9%
EPS NY
-11.9%
52W%
5.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +177.8% upside
Quality
3/30
Valuation
16/30
Growth
0/25
Stability
3/10
LT Trend
1/5
Upside
+177.8%
Quality
6
Click a card to see score breakdown Full Analysis →
Seres Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 66
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
MCRB

Latest News

—
Caricamento notizie per MCRB…
stock quote shares MCRB – Seres Therapeutics, Inc. Stock Price stock today
news today MCRB – Seres Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MCRB – Seres Therapeutics, Inc. yahoo finance google finance
stock history MCRB – Seres Therapeutics, Inc. invest stock market
stock prices MCRB premarket after hours
ticker MCRB fair value insiders trading